Riku Louhimo

I am a Lead Data Scientist and Researcher currently working as the senior advisor for AI and data at Varma Mutual Pension Insurance Company.

My professional interests include AI strategy, product development process in data science, data integration and mining, data-analysis and processing automation, data visualization as well as clear and efficient data reporting. I consider myself a part-time cancer researcher with an interest in genomic characterization of tumors.

From 2015 to 2020 I was working as the Product Manager for large-scale data at the Finnish Institute of Occupational Health (FIOH).

Before joining FIOH, I compeleted a Bioinformatics PhD at Sampsa Hautaniemi’s lab (University of Helsinki) and did a brief stint in Florian Markowetz’s group (Cancer Research UK, Cambridge). I got my PhD from the University of Helsinki in 2015. I also am a co-founder and data-analysis consultant for the now defunct Significo Research Ltd which provided data science and analytics services for public and private medical and life-science sectors.

News

• 19 October 2020: My blog post about work-ability data at Varma's website (in Finnish only)
• 14 September 2019: Check out FIOH’s Work-life Knowledge service! I was managing the website’s production and the development team. The service was launched in March 2019 and we are currently expanding its content and user-base.
• 7 February 2018: At FIOH we are starting to build a new platform for Finnish work life data. We are conducting extensive work shops with all key stakeholders in the spring of 2018. Stay tuned for further developments.
• 21 June 2017: I was heavily involved in getting FIOH to publish our first large, open data set. Check it out from here (unfortunately only in Finnish, also news item).

Publications

My full list of publications you can find from Google Scholar.

Latest publications:

• Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes. A Alkodsi, A Cervera, K Zhang, R Louhimo, L Meriranta et al. Leukemia, 11 June 2019.
• Drug sensitivity screening and genomic characterization of 45 HPV-negative head and neck carcinoma cell lines for novel biomarkers of drug efficacy. Tatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo et al. Molecular Cancer Therapeutics 17(9), 2060-2071, 2018.
• Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1. Siri A Tvingsholm, et al. Oncogenesis 7(2), 14, 2018.

Software

Bitbucket github

I am also an active user and contributor to the finest pipeline engine known to mankind, Anduril (website, Wikipedia).

Scientific software (mostly no longer maintained):

• CNAmet
• GOPredict
• geninter
• CN2GEAlgo

Contact

Riku Louhimo,
Varma Mutual Pension Insurance Company
Helsinki, Finland

Työelämätieto (Work-life Knowledge Service)
PGP public key (Fingerprint: ABB4 0331 F3F9 890D 5909 89E4 B761 61EC 080B 21F0)

User tracking

You are being tracked with Google Analytics. Google swears that your data remain anonymous but with Google you can never tell. You can block Google Analytics tracking in various ways, most of which are probably ineffective considering how much data Google already has on your browser, IP addresses and browsing habits.

Last updated: Apr 1, 2024.
Copyright Riku Louhimo.
Generated with pandoc + markdown + github css.